Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$963,609,833
+$114,168,275 QoQ
Shares Held
3,829,319
-2.0% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#53
of 4,153 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vanguard Global Advisers, LLC holds $6,555,824,144 across 12 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,707,634 | $2,048,187,619 | |
| 2 | JNJ |
Johnson & Johnson
|
5,244,145 | $1,331,855,505 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
3,829,319 | $963,609,833 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,512,538 | $708,361,133 | |
| 5 | AMGN |
Amgen Inc
|
1,170,547 | $423,878,479 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,704,155 | $341,642,942 | |
| 7 | PFE |
Pfizer Inc
|
12,795,058 | $308,104,996 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,700,737 | $270,856,465 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963,609,833 | 3,829,319 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $849,441,558 | 3,905,658 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||